Progressive Care, Inc., through its subsidiary, Pharmco, LLC, provides prescription pharmaceuticals to individuals and institutions in south Florida. The company operates a retail pharmacy that specializes in the sale of anti-retroviral medications and related patient care management; the sale and rental of durable medical equipment (DME), such as hospital beds,...
RXMD retesting key support on a strong price flush to shake out weak hands. This comes as the company acquires a leading Telehealth platform and readies to expand its operational reach to all 50 US states (from 14) while on pace to record a projected $50 million in 2020 revenues. Progressive Care Inc. (OTCMKTS:RXMD) is making moves that place it at the heart of...
RXMD shares have been trending higher over the past two months, forming a base with the potential to break out significantly higher on a move back above the $0.07 level. This follows another spectacular quarter with Q2 numbers out earlier this week. The company is also transitioning at the top spot, with a CEO change underway to position RXMD for an uplist onto...
RXMD is a stock we liked a lot back at the start of July. And we still like it. The company continues to expand in its FL Covid testing range and it keeps putting up monster growth data. The breakouts are coming in a stepwise trend. And the company has signaled a coming potential Nasdaq uplist.
APT was a play we signaled back in the $18.50 area as a possible breakout R/R setup. Now, we have seen $25 as virus numbers rip, but many other PPE sources have come along. Longs don't want to see $20 breached to the downside from here.
RXMD is sporting a number of positive technical attributes, including a successful hold as former breakout resistance became viable support in mid-June at the $0.04 level in confluence with new bull trendline support and a 40 oversold RSI print. That has been followed by an aggressive breakout back above both the 50- and 200-day major MA's. The company has been...
RXMD has double-bottom key support lined up with a major MACD buy signal after breaking above its recent downtrend line in yesterday's action. This is a Coronavirus play at the leading edge in both telehealth and home pharmacy delivery. • Telehealth regulations have been dropped to allow it to brace our healthcare system against exponential COVID-19 case...
RXMD is in a clear bullish technical posture: at key support with multiple touches over two years and an RSI print under the "30" bull signal level. In other words, it's oversold and triggering key support in a very large time-frame bull trend. • Telehealth regulations have been dropped to allow it to brace our healthcare system against exponential COVID-19 case...
RXMD put in a key low on a glaring bullish MACD divergence. Now we see to be angling toward an ascending triangle breakout that could bring the dime level into play. ------------------------- Progressive Care Inc (OTCMKTS:RXMD) Progressive Care has been putting up huge growth data in recent months, vaulting onto our radar as one of the most interesting penny...
RXMD has the big breakout lined up well at this point, with accumulation/distribution indicator rising through a basing process that displays a clear shift in trend from down to up, further confirmed by Ichimoku Cloud signal. This is percolating, with the key line to set off the fireworks at $0.07. Once it gets there, you won't be able to catch up to it. Smart...
RXMD The RXMD chart continues to look ripe for potential upside. The key to this pattern is the pivot at the higher low around Thanksgiving in the nickel/share area. That came at the 61.8% Fib retrace zone with the 50-day MA providing support along with the retest of the broken down trend line. The stock has been ripping in recent days and looks set to try for a...
RXMD The action in shares of Progressive Care Inc. (OTCMKTS:RXMD) has been the action of a stock that is coming to terms with a new phase of trend: a strong bullish upward trend. The technical signals on display here are very clear as we read the tea leaves. The lowest low – back in early November – came off of a type-specimen bullish MACD divergence, which led...
RXMD RXMD shares have held on the retest of the topside of the broken downward trend following bullish signals on both RSI and MACD. That's a huge technical signal supporting the thesis that a major new upward trend is now underway in the stock following the established "higher low" support. On the conference call following its Q3 report, the company...
RXMD Sometimes, everything lines up just right. That's the case for RXMD right now, as the stock tests the top side of its former -- now broken -- down trend line, which was shattered last month after an explosive upside triggering of a big MACD Bull Divergence Buy Signal, which we covered at the time. That was the first big opportunity. This is the...
RXMD Of course there will be some folks wanting to bank some profits here -- the stock was up as much as 135% this month alone, and is still up over 70% in November. But the technical action suggests a new, fresh bullish trend now underway, meaning that the opportunity here will be to take advantage of pullbacks. The fundamental trend has changed as well, with...
RXMD $RXMD shares are going nuts today on big volume after company reported explosive growth for Q3 and outlined an ambitious initiative to disrupt the multi-billion dollar telehealth opportunity. The stock has already blown through downtrend resistance and range resistance and there may be nothing but upside ahead given that we are talking about shares that...
RXMD The technical verdict is in on RXMD: the upside looks like the right side following confirmation of last week's MACD bullish divergence signal. About RXMD RXMD (Progressive Care Inc.) operates a retail pharmacy that specializes in the sale of anti-retroviral medications and related patient care management; the sale and rental of durable medical equipment...